when will glp 1 drugs become generic GLP-1 Medications be Available? FDA approves 3rd generic liraglutide

Nature 512 , 218222 (2014) Peisley, A

Their findings were striking: AKD patients treated with GLP-1 RAs experienced lower rates of major adverse kidney events (MAKEs), which include complications like the need for dialysis, worsening kidney function, and even death due to kidney failure

Honestly, anything that feels like comfort food without being greasy

Scherer, Newgard

World CNS Series will capitalise on continued momentum in 2026 with a greater range than ever of intimate, industry-first meetings built to support R&D across neurodegeneration, neuroinflammation, neuropsychiatry and neuromuscular

He positions AI as "just as smart and creative as we are and even more so in the future." The Cadence collaboration is the proof point: AI was given raw transcriptomic data and returned a biological age measurement method that the human scientists had not conceived of